Page 1915 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

1342 Index

High-risk surgical patient, preoperative Hydrocephalus, acute, 776 incidence of, 112
assessment of, 1053–1060 Hydromorphone, 151 symptoms and signs of, 978, 978t
Histamine, 1272–1273 Hydrostatic edema, 794 treatment of, 979
Histoplasmosis, 636 Hydrostatic pressure, 239 Hypokalemia, 951–954, 951t, 953f, 976
HIV. See Human immunodeficiency virus ß-Hydroxybutyrate, 971 Hypokalemic periodic paralysis, 951
(HIV) γ-Hydroxybutyrate, 1217 Hypomagnesemia, 952, 966–967, 966t
Homeland Security Exercise Evaluation Hydroxycobalamin, 1215 Hyponatremia, 777, 947–950, 947f, 948ft
Program (HSEEP), 58 Hydroxyethyl starch (HES), 928 asymptomatic, 949
Homozygous sickle cell disease, 903 Hydroxyurea for sickle cell disease, 914 hyposmotic, 947
Horner syndrome, 406 Hyperacute rejection, 1095 postoperative, 948
Hospital(s), organizing, for disaster Hypercalcemia, 877, 960–962, 961t, 962t, 991 symptomatic, 949, 949f
response, 60, 60ft Hypercapnia, pulmonary artery pressure thiazide-induced, 948
Hospital-acquired infections, 13–14 and, 317 Hypoparathyroidism, 958–959
Hospital-acquired pneumonia, 585–587 Hypercapnic respiratory failure, 516 Hypoperfused states in pregnancy,
altered pathogenesis and Hypercoagulation state, 1046 1256–1257, 1256ft
pathophysiology, 585 Hyperglycemia, 98, 107, 1136–1137 Hypoperfusion, 261, 1118–1119
antibiotic therapy, 586–587, 586t Hyperglycemic crisis, 974–978 approach to, 235–238, 236t, 238f
diagnosis of, 585, 585t complications in, 976–977 injuries in, 794
etiologic spectrum, 585–586 differential diagnosis of, 976 Hypopharynx, 404
prevention, 587, 587t epidemiology/incidence of, 976 Hypophosphatemia, 486, 962–964, 963t, 964t
Hospital and community emergency planning, management of, 977–978, 977t Hyposmotic hyponatremia, 947
integration of pathophysiology of, 975 Hypotension, 112, 364
intensive-care unit into, presentation of, 975–976, 975t postintubation, 501
59–61, 60f, 62 Hyperglycemic hyperosmolar in surgical patient, 1047, 1047f
Hospital Incident Command System, nonketotic coma, 975 Hypothalamic-pituitary-adrenal (HPA) axis
60, 60ft Hyperglycemic hyperosmolar nonketotic state, failure in acute illness, 982, 982t
Hospitalists, 17 975 Hypothermia, 243, 1311–1317, 1326
Host immune response, 564 Hyperglycemic induced brain injury, 112 in burn patients, 1186
House officers, 17 Hyperhydration, hyperpyrexia, clinical presentation, 1312–1314,
Human corona virus, 676 hyperexcitability, and hyperrigidity 1313t, 1314f
Human herpes virus 6 (HHV-6), 671, 676 (HYPER), 1325 defined, 1311
Human immunodeficiency virus (HIV), Hyperinflation, 484–485 epidemiology of, 1312
625, 676, 1302, 1302t Hyperkalemia, 327, 954–957, 954t, 956t induced, 818
antiretroviral therapy in ICU, 626–628, 627t Hyperleukocytosis syndrome, 871–872 history of, 174–175
changing spectrum of ICU presentations Hypermagnesemia, 967–968 management of, 1314–1317, 1315f
among infected patients in the ART Hypernatremia, 945–947, 946ft, 947f mechanisms of, 175–176, 175f
era, 628–629 Hyperosmolar hyperglycemic state, 974 potential benefits of, 1135
Cryptococcus neoformans, 638–639, 639f Hyperosmolar therapy, 1133–1134 prevention of, 1317
diffuse brain disease (dementia and in intracranial pressure management, 808 prognosis, 1317
encephalopathy), 640 Hyperparathyroidism regulation of body temperature,
epidemiology of, 625 primary, 960 1312, 1312t
focal neurologic disease, 639–640, 640f tertiary, 960 spinal injuries and, 1150–1151
fungal infections and, 636 Hyperphosphatemia, 931, 937, 964–965, 965t therapeutic, 809–810
infection control and, 30 Hypersensitivity, 327, 900–901 Hypothyroidism, thyroid disease and,
postexposure prophylaxis, 641 Hypersensitivity syndrome/drug reaction 986–987
Mycobacteria tuberculosis, 635–636 with eosinophilia and systemic Hypovolemia
natural history, 626 symptoms, 1289–1290, 1290t delayed resuscitation of, 252
neurologic manifestations in, 637–638, Hypertension, 776 nonhemorrhagic, 237
637–638t Hypertensive encephalopathy and treating, 262
opportunistic infections, 640–641 eclampsia, 819, 820f Hypovolemic shock, 237, 254–256, 254f,
pathogenesis, 625–626, 626t Hypertensive renal crisis, scleroderma and, 255–256, 255f, 260
Pneumocystis jiroveci pneumonia, 1243–1244 Hypoxemia, 243, 243f, 1125
629–635 Hyperthermia, 557, 837 arterial, 1143
clinical and radiologic features, noninfectious causes of, 559–561 exercise-induced, 518
630, 635f spinal injuries and, 1150–1151 identifying causes of, 243
diagnosis of, 630–631 Hypertonic saline solutions, 809 incremental approach to management of
management of, 632, 632–634t Hypertrophic cardiomyopathy, 295 patients with severe, 471, 471f, 472f
prognosis, 634–635 Hyperventilation, 1133, 1319 mechanisms of, 320
pulmonary infiltrates in HIV-infected prophylactic, 812 refractory, 517
individuals, 636–638, 637–638t Hypervolemia, 197f, 198 Hypoxemic respiratory failure, 381–382
respiratory disease complicating infection, Hypocalcemia, 931–932, 957–960, Hypoxemic versus ventilatory failure, 372,
629, 629f 958t, 959t, 960t 373t
Human T-cell lymphotropic virus type I acute, 959 Hypoxia, 949
(HTLV-I), 676 Hypoglycemia, 978–979 Hypoxic hepatitis, 1023
Hutchinson sign, 1302 causes of, 978, 979t Hypoxic-ischemic encephalopathy, 835
Hydrocephalic edema, 794 evaluation of, 979 cause of, 835

Index.indd 1342 23-01-2015 15:33:52